Skip to Main Content
Digestive Diseases
YSM Home

INFORMATION FOR

February 2025

Message from Chief Loren Laine, MD

February 2025

Dear Colleagues,

The sun is setting a little later each day, providing us with some extra light and a reminder that while it is still frigid outside, spring is just around the corner. As we look to warmer days, we are beginning to plan in earnest for the upcoming academic year.

Starting next academic year, our gastroenterology and hepatology fellowship program will expand from 18 to 21 fellows (with an average of seven new fellows each year). Thank you to our fellowship program director, David Assis, MD, who helped shepherd this program expansion through the Accreditation Council for Graduate Medical Education (ACGME) approval process. We have an excellent fellowship program, and I’m glad we will have the opportunity to help train even more fellows in the next academic year.

In other good news, we have learned that our section will be extremely well-represented at the upcoming Digestive Disease Week, which will take place on May 3-6 in San Diego. Congratulations to everyone who was selected to deliver an oral or poster presentation at the event!

U.S. News and World Report recently opened up voting for their 2025-2026 rankings. I encourage you to take a moment to cast your reputation vote in support of our section and our colleagues. Board-certified physicians can vote through Doximity

from now through March.

Please mark your calendar for upcoming lectures and events throughout the spring:

  • February 25-26: Kushlan Visiting Professorship: Shailja Shah, MD, MPH
  • April 23-24: Klatsin/Boyer Professorship: Gerald Shulman, MD, PhD
  • April 26: 2nd Annual IBD Conference
  • May 3-6: Digestive Diseases Week

As always, I hope you enjoy reading about the inspiring and collaborative efforts in clinical care, research, and education by the members of our section. Thank you for everything you do.

Sincerely,

Loren Laine, MD
Professor of Medicine (Digestive Diseases)
Section Chief, Digestive Diseases, Yale School of Medicine
Medical Chief, Digestive Health, Yale New Haven Health

February 2025 Newsletter Issue

  • Today
  • Previous 7 Days
  • Previous 30 Days
  • Select Dates
February 19, 2025

Improving Ergonomics in Endoscopy to Prevent Injury and Improve Quality

Over the past decade, there has been a significant focus on reducing burnout to improve physicians' quality of life and retain a strong healthcare workforce. However, for proceduralists and other surgical specialists, disability is one of the most significant factors in determining if they leave the workforce early. Gyanprakash Ketwaroo, MD, MSc, associate professor of medicine (digestive diseases) and chief of endoscopy at the West Haven VA recently published a book, "Ergonomics for Endoscopy," with his colleagues. The book focuses on changes that can be put into place at every level to reduce strain and prevent injuries.

Read more
  • January 27, 2025

    Responding to Rise of Metabolic Liver Disease in Connecticut

    Metabolic liver diseases are on the rise in Connecticut. Yale faculty joined a new state working group to respond to the increase in the prevalence of these diseases. The working group recently issued recommendations to increase awareness and education and improve public health infrastructure.

    Read more
  • January 06, 2025

    Digestive Health CME Series Returning for 2025

    The Trust Your Gut continuing medical education (CME) series is returning for 2025 to provide physicians and advanced practice providers with world-class, evidence-based digestive disease education. Each webinar will be delivered by experts across the Yale School of Medicine.

    Read more
  • November 08, 2024

    Liver Cancer Screening: A New Tool for Improved Detection

    Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths. Screening efforts for this cancer focus on individuals diagnosed with viral hepatitis or those known to have irreversible liver scarring, or cirrhosis. Due in part to increasing rates of obesity, another major risk factor is emerging, metabolic dysfunction-associated steatotic liver disease (MASLD), but factors associated with MASLD are not included in current screening practices. In response, researchers at Yale have developed and validated a new risk score for hepatocellular carcinoma that considers these factors. Their work, “Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or...

    Read more
Get RSS Feed